Ex-Binance CCO accused of aiding and abetting CFTC rule violations
By 
Aaron Nicodemus2023-03-27T21:26:00
The Commodity Futures Trading Commission (CFTC) charged Binance and its founder with operating an illegal digital assets exchange.
The agency’s announcement Monday also included charges against former Binance Chief Compliance Officer Samuel Lim for aiding and abetting the exchange’s alleged violations of the Commodity Exchange Act (CEA) and CFTC regulations. Entities Binance Holdings Limited, Binance Holdings (IE) Limited, and Binance (Services) Holdings Limited were each named in the complaint, along with founder Changpeng Zhao.
The complaint, filed in U.S. District Court for the Northern District of Illinois, cited a number of violations at Binance, including:
Related articles
-
News BriefBinance pleads guilty, fined $4.3B over widespread U.S. law violations
Federal agencies hit Binance with more than $4.3 billion in penalties and imposed multiple compliance monitorships on the virtual currency exchange as punishment for its repeated and intentional violations of U.S. anti-money laundering laws, sanctions, and other regulations.
-
News BriefSEC charges Binance, founder in latest crypto crackdown
The Securities and Exchange Commission charged Binance Holdings, its U.S.-based affiliate BAM Trading Services, and their founder Changpeng Zhao with a series of securities law violations, including operating unregistered exchanges.
-
OpinionMessaging history damning in CFTC case against ex-Binance CCO
A cryptocurrency firm with a chief compliance officer found to not be handling the responsibilities of their role seriously is likely to face additional regulatory scrutiny, as evidenced by the Commodity Futures Trading Commission’s action against Binance.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”